Company

Amber Therapeutics

Biotechnology Research London, City of, United Kingdom 45 employees

Employees: 45
Contacts: 2
Emails: 2
Phones: 1

www.amber-tx.com LinkedIn Crunchbase

Amber Therapeutics Overview

Headquarters: London, City of, United Kingdom
Website: www.amber-tx.com
Industry: Biotechnology Research
Employees: 45
Founded: 2021
Funding: 101.8M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Amber Therapeutics

Amber Therapeutics was founded in 2021 with a mission to develop and deliver breakthrough neuromodulation therapies that can fundamentally transform outcomes in areas of unmet clinical need. With the acquisition of Finetech Medical Limited and Bioinduction Ltd in 2023, we are continuing to be the only UK based company in the field of designing and manufacturing long-term implantables. We have since grown into a multidisciplinary team, combining deep medical device experience with a culture and mindset focused on transformational innovation. Amber UI is the company’s first therapy, aiming to restore normal physiological function in women suffering with mixed urinary incontinence.

Amber Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Amber Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Kylie De Jager	Electronic Engineer - Team Lead - Biomedical Researcher		View
Nazir-Ahmed Karbanee	Biomedical Eng - Medical Devices	York, England, United Kingdom	Email
Murielle Thinard Mclane	Expanding Access to Minimally Invasive Care	San Francisco Bay Area, United States	Email Phone
Prof Tim Denison Freng	Professor of Engineering Science, and Royal Academy of Engineering Chair in Emerging Technology		View